USPTO serial 79371028
GCSA GLOBAL CLINICAL SITE ACCREDITATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 18, 2024
- Examiner
- CHOSID, ROBIN S
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GCSA GLOBAL CLINICAL SITE ACCREDITATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Global Clinical Site Assessment Limited
GB
Other trademarks owned by Global Clinical Site Assessment Limited
Global Clinical Site Assessment Limited
GB
Other trademarks owned by Global Clinical Site Assessment Limited
Global Clinical Site Assessment Limited
GB
Other trademarks owned by Global Clinical Site Assessment Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley M. Stohry
Bradley M. Stohry Reichel Stohry Dean LLP6151 Central AveIndianapolis, IN 46220United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Provision of business advice and assistance in the field of clinical trial site competency, practices and processes; gap analysis and process improvement, namely, business advice and management services, in the field of clinical trial site competency, practices and processes; human resource advice and management services in the field of clinical trial site competency, practices and processes; human resource process improvement services in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation to all of the aforementioned services | ACTIVE | — |
| 041 | Organisation of educational conferences, exhibitions and seminars for best practice sharing in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation all of the aforementioned services | ACTIVE | — |
| 042 | Quality evaluation, checking, auditing and assurance services in the field of clinical research site competency, practices and processes to determine conformity with certification standards; quality checking in the field of clinical trial site competency, practices and processes; quality auditing in the field of clinical trial site competency, practices and processes; quality evaluation of clinical research sites to determine conformity with established accreditation standards; quality evaluation of clinical research sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; clinical research and clinical trials quality evaluation services to determine conformity with established accreditation standards; information, advisory and consultancy services in relation to all the aforementioned services | ACTIVE | — |
| 045 | Reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trial site competency, practices and processes; review and preparation of regulations, standards and compliance procedures being legal services in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation to all of the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Global Clinical Site Assessment Limited
- Other trademarks owned by Global Clinical Site Assessment Limited
- Other trademarks owned by Global Clinical Site Assessment Limited
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named GCSA GLOBAL CLINICAL SITE ACCREDITATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 28, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 6, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 18, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 18, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 18, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 30, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 30, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 6, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 2, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 1, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |